Mirum appoints Saira Ramasastry to board; stockholders re-elect three directors

Mirum Pharmaceuticals, Inc.

Saira Ramasastry appointed to Mirum's board effective June 2, 2022; will serve on audit committee.
Ramasastry received option to purchase 34,000 shares vesting over three years; annual cash retainers of $40k (board) and $10k (audit).
At annual meeting, stockholders re-elected directors Laura Brege, Michael Grey, and Christopher Peetz to Class III terms expiring 2025.
Stockholders ratified Ernst & Young as independent auditor for FY2022 with overwhelming support.

item 5.02 item 5.07 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Saira Ramasastry

Director

MIRM · Mirum Pharmaceuticals, Inc.

Effective: 2022-06-02
Filed: June 6, 2022, 7:59 PM ET

On June 2, 2022, the Board of Directors (the "Board") of Mirum Pharmaceuticals, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Saira Ramasastry to the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Saira Ramasastry was appointed as Director at Mirum Pharmaceuticals, Inc..

Action: appointed
Role: Director

Exact text from the filing

On June 2, 2022, the Board of Directors (the "Board") of Mirum Pharmaceuticals, Inc. (the "Company"), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Saira Ramasastry to the Board, effective immediately.

View on SEC.gov

Mirum Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-167951

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.